2022 - Research.com Best Female Scientist Award
Emma Guttman-Yassky spends much of her time researching Immunology, Atopic dermatitis, Psoriasis, Immune system and Filaggrin. Her studies deal with areas such as Immunoglobulin E, Internal medicine, Disease and SCORAD as well as Atopic dermatitis. Her Internal medicine research incorporates themes from Gastroenterology and Placebo.
Her research integrates issues of Tumor necrosis factor alpha, Cytokine, Inflammation, CCL17 and Keratin 16 in her study of Psoriasis. Her Filaggrin study combines topics in areas such as Involucrin and FOXP3. Her Eczema Area and Severity Index research is multidisciplinary, relying on both Dupilumab and Tralokinumab.
Her primary areas of study are Atopic dermatitis, Immunology, Dermatology, Immune system and Psoriasis. Her Atopic dermatitis research integrates issues from Internal medicine, Disease and SCORAD. Her Internal medicine study incorporates themes from Gastroenterology and Placebo.
Her Inflammation, Filaggrin, T cell, Immunoglobulin E and Cytokine study are her primary interests in Immunology. Her Immune system study combines topics from a wide range of disciplines, such as Antigen and Pathogenesis, Pathology. The study incorporates disciplines such as Tumor necrosis factor alpha, Transcriptome and Interleukin 17 in addition to Psoriasis.
Her scientific interests lie mostly in Atopic dermatitis, Immunology, Dupilumab, Immune system and Dermatology. Eczema Area and Severity Index is the focus of her Atopic dermatitis research. Her Immunology research includes elements of Microbiome, Transcriptome and Personalized medicine.
As part of one scientific family, Emma Guttman-Yassky deals mainly with the area of Immune system, narrowing it down to issues related to the Pathogenesis, and often Immune tolerance. Her research in Dermatology intersects with topics in Moderate to severe, Double blind study, Biomarker and Interleukin 17. The concepts of her Psoriasis study are interwoven with issues in Dendritic cell, Human skin and Keratinocyte.
Emma Guttman-Yassky mainly investigates Atopic dermatitis, Internal medicine, Dupilumab, Dermatology and Eczema Area and Severity Index. She interconnects Clinical trial, SCORAD, Placebo, Disease and Biomarker in the investigation of issues within Atopic dermatitis. Her SCORAD research includes themes of Lebrikizumab, Immunology, Tralokinumab and Intensive care medicine.
Her work deals with themes such as Psoriasis, Clinical severity and Bioinformatics, which intersect with Biomarker. Her study focuses on the intersection of Psoriasis and fields such as Fold change with connections in the field of Immune system. Her work carried out in the field of Dermatology brings together such families of science as Double blind study and Interleukin 17.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Eric L. Simpson;Thomas Bieber;Emma Guttman-Yassky;Lisa A. Beck.
The New England Journal of Medicine (2016)
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
Lisa A. Beck;Diamant Thaçi;Jennifer D. Hamilton;Neil M. Graham.
The New England Journal of Medicine (2014)
Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.
K.E. Nograles;L.C. Zaba;E. Guttman-Yassky;J. Fuentes-Duculan.
British Journal of Dermatology (2008)
Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis.
Julia K. Gittler;Julia K. Gittler;Avner Shemer;Mayte Suárez-Fariñas;Judilyn Fuentes-Duculan.
The Journal of Allergy and Clinical Immunology (2012)
IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells
Kristine E. Nograles;Lisa C. Zaba;Avner Shemer;Judilyn Fuentes-Duculan.
The Journal of Allergy and Clinical Immunology (2009)
Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
Andrea Chiricozzi;Emma Guttman-Yassky;Emma Guttman-Yassky;Mayte Suárez-Fariñas;Kristine E. Nograles.
Journal of Investigative Dermatology (2011)
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis
Thomas Werfel;Jean-Pierre Allam;Tilo Biedermann;Kilian Eyerich.
The Journal of Allergy and Clinical Immunology (2016)
The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
Patrick M. Brunner;Emma Guttman-Yassky;Donald Y.M. Leung.
The Journal of Allergy and Clinical Immunology (2017)
Deciphering the Complexities of Atopic Dermatitis: Shifting Paradigms in Treatment Approaches
Donald Y.M. Leung;Emma Guttman-Yassky.
The Journal of Allergy and Clinical Immunology (2014)
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.
Shinji Noda;Mayte Suárez-Fariñas;Benjamin Ungar;Benjamin Ungar;Soo Jung Kim.
The Journal of Allergy and Clinical Immunology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: